City

Nijmegen (1)

Saint Louis (1)

Suzhou (1)

Condition

Acute Myeloid Leukemia, Relapsed, Adult (3)

Acute Myeloid Leukemia (1)

Acute Myeloid Leukemia Refractory (1)

Overall Status

Completed (1)

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

phase 1/phase 2 (1)

Sponsor

Radboud University Medical Center (1)

The First Affiliated Hospital of Soochow University (1)

Washington University School of Medicine (1)

Collaborator

Dutch Cancer Society (1)

Janssen Pharmaceuticals (1)

Jining Medical University (1)

National Cancer Institute (NCI) (1)

National Institutes of Health (NIH) (1)

Intervention

bone marrow biopsy/aspirate (1)

buccal swab (1)

cdiag regimen (1)

decitabine (1)

il-2 (1)

peripheral blood draw (1)

skin biopsy (1)

ucb-nk cells (1)

Study Documents

Intervention Type

drug (3)

biological (1)

procedure (1)

Funder Type

Other (3)

Study Type

Interventional (3)

acute myeloid leukemia, relapsed, adult

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Acute Myeloid Leukemia, Acute Myeloid Leukemia, Relapsed, Adult Trial in Saint Louis (Decitabine, Bone marrow biopsy/aspirate,

Terminated

Acute Myeloid Leukemia
Acute Myeloid Leukemia, Relapsed, Adult

Decitabine
+4 more

Saint Louis, Missouri

Washington University School of Medicine

May 9, 2022

Acute Myeloid Leukemia, Relapsed, Adult Trial in Suzhou (CDIAG regimen)

Completed

Acute Myeloid Leukemia, Relapsed, Adult

CDIAG regimen

Suzhou, Jiangsu, China

The First Affliated Hospital of Soochow University

Mar 16, 2022

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, Relapsed, Adult Trial in Nijmegen (UCB-NK cells, IL-2)

Recruiting

Acute Myeloid Leukemia Refractory
Acute Myeloid Leukemia, Relapsed, Adult

UCB-NK cells
IL-2

Nijmegen, Netherlands

Radboud University Medical Center

Nov 10, 2021